Evidence map›Paper›PMID 22692201›Full record

ArticleThe Journal of biological chemistry2012

Characterization of the human SNM1A and SNM1B/Apollo DNA repair exonucleases.

Blanka Sengerová, Charles K Allerston, Mika Abu, Sook Y Lee, Janet Hartley, Konstantinos Kiakos, Christopher J Schofield, John A Hartley, Opher Gileadi, Peter J McHugh

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Two-Step Validation Approach for Tools To Study the DNA Repair Enzyme SNM1A.Chembiochem : a European journal of chemical biology · 2023
    Article
  9. Article
  10. Structure and Function of SNM1 Family Nucleases.Advances in experimental medicine and biology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Blanka SengerováDepartment of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Charles K Allerston
Mika Abu
Sook Y Lee
Janet Hartley
Konstantinos Kiakos
Christopher J Schofield
John A Hartley
Opher Gileadi
Peter J McHugh
John Radcliffe Hospital · GBCancer Research UK · GBUniversity of Oxford · GB

Funding

Cancer Research UK 9994Wellcome Trust 092809
6 · The paper itself

Abstract

Human SNM1A and SNM1B/Apollo have both been implicated in the repair of DNA interstrand cross-links (ICLs) by cellular studies, and SNM1B is also required for telomere protection. Here, we describe studies on the biochemical characterization of the SNM1A and SNM1B proteins. The results reveal some fundamental differences in the mechanisms of the two proteins. Both SNM1A and SNM1B digest double-stranded and single-stranded DNA with a 5'-to-3' directionality in a reaction that is stimulated by divalent cations, and both nucleases are inhibited by the zinc chelator o-phenanthroline. We find that SNM1A has greater affinity for single-stranded DNA over double-stranded DNA that is not observed with SNM1B. Although both proteins demonstrate a low level of processivity on low molecular weight DNA oligonucleotide substrates, when presented with high molecular weight DNA, SNM1A alone is rendered much more active, being capable of digesting kilobase-long stretches of DNA. Both proteins can digest past ICLs induced by the non-distorting minor groove cross-linking agent SJG-136, albeit with SNM1A showing a greater capacity to achieve this. This is consistent with the proposal that SNM1A and SNM1B might exhibit some redundancy in ICL repair. Together, our work establishes differences in the substrate selectivities of SNM1A and SNM1B that are likely to be relevant to their in vivo roles and which might be exploited in the development of selective inhibitors.

Indexed as

Cell Cycle ProteinsChelating AgentsDNADNA-Binding ProteinsDNA CleavageDNA DamageDNA Repair EnzymesDNA, Single-StrandedEnzyme AssaysEnzyme InhibitorsEscherichia coliExodeoxyribonucleasesFluoresceinFluorescent DyesHumansHydrogen-Ion ConcentrationCell Cycle ProteinsChelating AgentsDCLRE1A protein, humanDCLRE1B protein, humanDNADNA-Binding ProteinsDNA Repair EnzymesDNA, Single-StrandedEnzyme InhibitorsExodeoxyribonucleasesFluoresceinFluorescent DyesMagnesiumNuclear ProteinsRecombinant ProteinsRNA

Identifiers

PMID22692201
PMCPMC3406710
OpenAlexW2046053218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.